“The Part That Died”
Editor's Note: Patient Worthy is pleased to share this article from our friends at Elephants & Tea, originally written by Cecily Liu. To see the article in its original format,…
Continue Reading
“The Part That Died”
Jenna’s Journey with Neuroendocrine Tumors (NETs)
I'm Jenna, a 36-year-old married mother of one son, and I have neuroendocrine cancer (NETs). It is a rare type of cancer, and 60% of the time, once a person…
Continue Reading
Jenna’s Journey with Neuroendocrine Tumors (NETs)
EMA Recommends Orphan Drug Status for BioInvent’s BI-1808 in Cutaneous T-Cell Lymphoma
As reported by PharmaBiz, the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has issued a positive opinion supporting Orphan Drug Designation (ODD) for BioInvent’s BI-1808, an investigational anti-TNFR2…
Continue Reading
EMA Recommends Orphan Drug Status for BioInvent’s BI-1808 in Cutaneous T-Cell Lymphoma
New Liposomal Chemotherapy Agent Shows Breakthrough Potential Against Resistant Tumors
As reported on World Pharma News, a collaborative research team from the Medical University of Vienna, HUN-REN Research Centre for Natural Sciences, and Eötvös Loránd University has unveiled a promising…
Continue Reading
New Liposomal Chemotherapy Agent Shows Breakthrough Potential Against Resistant Tumors
Merck’s Welireg Shows Promise in Kidney Cancer Across Two Major Trials
Merck & Co. announced positive results from two Phase 3 studies of its kidney cancer drug Welireg, signaling potential expansion into earlier stages of disease. As reported on BioPharmaDive, in…
Continue Reading
Merck’s Welireg Shows Promise in Kidney Cancer Across Two Major Trials
How DNA Technology Can Guide Treatment in Muscle Invasive Bladder Cancer
Author's Note: Patient Worthy began following Natera following their presentation at the American College of Medical Genetics conference many years ago. Natera has been known for its advances in prenatal…
Continue Reading
How DNA Technology Can Guide Treatment in Muscle Invasive Bladder Cancer
“My Own Worst Enemy” – Anna’s Experience with Hodgkin Lymphoma
Editor's Note: Patient Worthy is honored to share this article from our friends at Elephants & Tea. To see the article in its original form, please click here. Dear Cancer,…
Continue Reading
“My Own Worst Enemy” – Anna’s Experience with Hodgkin Lymphoma
Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples
Biomarker analysis plays a pivotal role in cancer care and research, guiding the development of targeted therapies and enabling personalized treatment plans. While next-generation sequencing (NGS) has revolutionized the ability…
Continue Reading
Navigating the Challenges of Biomarker Testing in Oncology: Innovations for Low-Yield Samples
Datroway Shows Survival Benefit in Late-Stage Trial for Triple-Negative Breast Cancer
AstraZeneca and Daiichi Sankyo have announced promising Phase 3 trial results for Datroway, their investigational antibody-drug conjugate (ADC) targeting triple-negative breast cancer (TNBC). The trial demonstrated that Datroway significantly slowed…
Continue Reading
Datroway Shows Survival Benefit in Late-Stage Trial for Triple-Negative Breast Cancer
Early Research on Two Tough Cancers
Pancreatic cancer took Alex Trebek, Michael Landon, Ruth Bader Ginsburg, Luciano Pavarotti, Steve Jobs, Patrick Swayze, and my dear friend Amy. Glioblastoma (GBM) took Senators John McCain and Ted Kennedy,…
Continue Reading
Early Research on Two Tough Cancers
The Unspoken Guilt of Living
Editor's Note: Patient Worthy is honored to share this story from our friends at Elephants & Tea. To see the article in its original form, please click here. Original author…
Continue Reading
The Unspoken Guilt of Living
Rare Cancer Explorer 1.0 (RaCE 1.0): A Game-Changer for Integrative Rare Cancer Research
Rare cancers, defined by their low incidence, collectively constitute nearly a quarter of all cancer diagnoses in the US and Europe, and represent a significant public health challenge. Despite their…
Continue Reading
Rare Cancer Explorer 1.0 (RaCE 1.0): A Game-Changer for Integrative Rare Cancer Research
New Genomic Insights Reveal Unique CLL Patterns in African American Patients
Recent research has brought to light striking genetic differences in chronic lymphocytic leukemia (CLL) among African American (AA) patients, suggesting that their disease may follow a distinct course compared to…
Continue Reading
New Genomic Insights Reveal Unique CLL Patterns in African American Patients
Jazz Pharmaceuticals Secures Historic FDA Approval for First CNS Glioma Therapy
Jazz Pharmaceuticals plc has taken a major leap in rare cancer treatment with the recent FDA accelerated approval of Modeyso (dordaviprone), the first-ever therapy for relapsed H3 K27M-mutated diffuse midline…
Continue Reading
Jazz Pharmaceuticals Secures Historic FDA Approval for First CNS Glioma Therapy
Jhonnatan’s Fight Against Gastric Cancer
Jhonnatan's recent journey with gastric cancer at age 36 ignited a passion within him to share his story and advocate for others. What began as a personal effort to keep…
Continue Reading
Jhonnatan’s Fight Against Gastric Cancer
Unlocking Personalized Immunotherapy: New Immune Biomarkers Identified in Pediatric Germ Cell Tumors
A groundbreaking study from the Molecular Oncology Research Center at Hospital de Amor in Barretos, Brazil, is paving the way for more personalized and less toxic treatments for children with…
Continue Reading
Unlocking Personalized Immunotherapy: New Immune Biomarkers Identified in Pediatric Germ Cell Tumors
Brian’s Journey with Mantle Cell Lymphoma
In 2019, I left my job to start working for myself. Things were going well until March 2020, when the pandemic hit. In January of 2021, I said to myself,…
Continue Reading
Brian’s Journey with Mantle Cell Lymphoma
Microbial Allies: How Bacteria Are Revolutionizing Cancer Treatment
In a breakthrough study, scientists have uncovered a surprising ally in the fight against cancer: the bacteria living within tumors. According to World Pharma News, an international team led by…
Continue Reading
Microbial Allies: How Bacteria Are Revolutionizing Cancer Treatment
Simple Combined Test Offers New Hope for Improved Outcomes in Gastric Cancer
A newly developed assessment method that brings together a blood-based measurement and a physical body metric is showing promise for forecasting both survival chances and nutritional health in patients battling…
Continue Reading
Simple Combined Test Offers New Hope for Improved Outcomes in Gastric Cancer
SilvaStrong: Unveiling the Unexpected
Life has a way of catching us off guard when we least expect it. For me, it all started with severe stomach pains that led to an unexpected hospital visit.…
Continue Reading
SilvaStrong: Unveiling the Unexpected
Cancer: It Sucks at Any Age
Acknowledgement: Patient Worthy is proud to share this article from our friends at Elephants & Tea. To see the article in its original form, please click here. I wish someone…
Continue Reading
Cancer: It Sucks at Any Age
Photo courtesy of Ethan Zohn
Rare Community Profiles: From Survivor to Advocate: Ethan Zohn on Cannabis Rescheduling and Cancer Care
Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…
Continue Reading
Rare Community Profiles: From Survivor to Advocate: Ethan Zohn on Cannabis Rescheduling and Cancer Care
Fotocitizen / Pixabay
Rare Community Profiles: “A Ballsy Sense of Tumor:” How Justin’s Testicular Cancer Diagnosis Led Him to Advocacy Around Men’s Health
Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…
Continue Reading
Rare Community Profiles: “A Ballsy Sense of Tumor:” How Justin’s Testicular Cancer Diagnosis Led Him to Advocacy Around Men’s Health
1 in 10 Million: 20-Year-Old Diagnosed with Stage IV Neuroblastoma
Ask any doctor about neuroblastoma and they'll tell you: this rare cancer, which forms from immature nerve cells, predominantly affects children who are five years old or younger. So when…
Continue Reading
1 in 10 Million: 20-Year-Old Diagnosed with Stage IV Neuroblastoma
Photo by sydney Rae on Unsplash
Care Assessment Need (CAN) Score Could Improve Care for Veterans with Basal Cell Carcinoma
Coordinating medical care can be complex, especially when you are older. If you are dealing with a health condition like cancer, you might be wondering: how long can/will I…
Continue Reading
Care Assessment Need (CAN) Score Could Improve Care for Veterans with Basal Cell Carcinoma
